Callan Family Office’s W.R. Berkley WRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.78M Buy
53,649
+12,847
+31% +$861K 0.07% 240
2026
Q1
$2.7M Sell
40,802
-12,466
-23% -$859K 0.06% 292
2025
Q4
$3.74M Buy
53,268
+23,779
+81% +$1.75M 0.08% 235
2025
Q3
$2.26M Sell
29,489
-5,414
-16% -$385K 0.07% 249
2025
Q2
$2.56M Buy
34,903
+28,005
+406% +$2.01M 0.08% 237
2025
Q1
$491K Sell
6,898
-12,694
-65% -$778K 0.04% 322
2024
Q4
$1.15M Buy
+19,592
New +$1.17M 0.07% 225

Other funds holding WRB

Callan Family Office's WRB Position: Q2 2026 in Review

Callan Family Office increased its W.R. Berkley (WRB) stake by 31% in Q2 2026, buying an estimated $861K and bringing the position to 53,649 shares worth $3.78M. The position accounts for 0.07% of the portfolio, ranked #240.

Callan Family Office first reported a position in WRB in Q4 2024 and has held it in 7 quarters since. 949 funds tracked by Wall St. Rank hold WRB as of Q2 2026.

  • Callan Family Office held 53,649 shares of W.R. Berkley worth $3.78M as of Q2 2026.
  • Callan Family Office bought 12,847 W.R. Berkley shares in Q2 2026, an estimated $861K.
  • W.R. Berkley made up 0.07% of Callan Family Office's portfolio in Q2 2026, its #240 holding.
  • Callan Family Office first reported a position in W.R. Berkley in Q4 2024 and has held it in 7 quarters since.
  • 949 funds tracked by Wall St. Rank held W.R. Berkley as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.